The Role of Biomarkers in Community-Acquired Pneumonia: Predicting Mortality and Response to Adjunctive Therapy

Critical Care - United Kingdom
doi 10.1186/cc7028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Predicting Pneumococcal Community-Acquired Pneumonia in the Emergency Department

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2014English

Empiric Therapy of Community-Acquired Pneumonia

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Prognostic Assessment in Community-Acquired Pneumonia by Pneumonia Severity Scores and Biomarkers

Critical Care
Critical CareIntensive Care Medicine
2010English

Antibacterial Therapy of Community-Acquired Pneumonia in Children

CHILD`S HEALTH
2018English

One-Year Mortality in Patients With Community-Acquired Pneumonia

Journal of Respiratory Infections
2017English

Low Procalcitonin, Community Acquired Pneumonia, and Antibiotic Therapy

The Lancet Infectious Diseases
Infectious Diseases
2018English

Antimicrobial Therapy for Community-Acquired Pneumonia in Adults

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2002English

Validation of Scoring Systems for Predicting Severe Community-Acquired Pneumonia

Internal Medicine
Internal MedicineMedicine
2011English

Severe Community-Acquired Pneumonia: Risk Factors for In-Hospital Mortality

Critical Care
Critical CareIntensive Care Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy